Kyrieckos Aleck
Clinical Genetics (M.D.) · Albuquerque, NMNPI 1891767307
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $317,170 of the $429,218 with a category attached, or 73.9%. Sanofi accounts for 65.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $120,227 and has fallen 64.5% since, to $42,658 in 2025.
Across 439 payments — averaging $977.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$280K
- Ultragenyx Pharmaceutical Inc.$68K
- Takeda Pharmaceuticals U.S.A., Inc.$34K
- AstraZeneca$17K
- Shire North American Group Inc$13K
- Kyowa Kirin, Inc.$12K
- plus $6K from 6 others
Across 81 payments — averaging $10,251 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$528K
- Shire North American Group Inc$176K
- Chiesi USA, Inc.$103K
- Biomarin Pharmaceutical Inc.$14K
- Pfizer$9K
What the payments were for
- Consulting fees$55,82513%
- Speaking & faculty fees$317,17074%
- Travel & lodging$47,41511%
- Food & beverage$8,6442%
- Education$1640%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 228 | $279,958 |
| Ultragenyx Pharmaceutical Inc. | 87 | $67,532 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $33,731 |
| AstraZeneca | 21 | $16,735 |
| Shire North American Group Inc | 15 | $12,931 |
| Kyowa Kirin, Inc. | 15 | $11,857 |
| Amicus Therapeutics, Inc. | 8 | $4,003 |
| Chiesi USA, Inc. | 2 | $2,144 |
| Biomarin Pharmaceutical Inc. | 4 | $199 |
| Travere Therapeutics, Inc. | 22 | $96 |
| Spark Therapeutics, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Albuquerque
- Tom CushingAlbuquerque$160
- Daniel PiqueAlbuquerque$139
- Kiley QuintanaAlbuquerque$20
- Stirling PuckSanta Fe$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.